PsychoGenics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PsychoGenics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7586
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PsychoGenics Inc (PsychoGenics) is a preclinical contract research organization that offers treatment for CNS and orphan disorders.The company’s capabilities include electrophysiology, behavioral testing, translational EEG, molecular biology, quantitative histology and microdialysis. Its proprietary platforms SmartCube, NeuroCubeand PhenoCube are used to screen thousands of compounds forCNS activity and also identify drugs to treat neuropsychiatric disorder. The company also offers support research in areas such as huntington’s disease, parkinson’s disease, autism spectrum disorders, psychosis/schizophrenia, alzheimer’s disease and spinal muscular atrophy, among others. PsychoGenics is headquartered in Paramus, New Jersey, the US.

PsychoGenics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PsychoGenics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Blue Oak Pharma Enters into Agreement with PsychoGenics 10
Resilience Therapeutics Enters into Drug Discovery Agreement with PGI 11
PsychoGenics Extends Drug Discovery Agreement with Sunovion Pharma 12
Afraxis And PsychoGenics Enter Into Partnership To Offer Afraxis’ ESP Technology For Drug Discovery 13
Licensing Agreements 14
PsychoGenics Enters into Licensing Agreement with National Institute of Mental Health 14
Amarantus Enters Into Licensing Agreement With PGI Drug Discovery For Eltoprazine 15
PsychoGenics Enters into Licensing Agreement with University of California, San Diego 17
PsychoGenics Enters into Licensing Agreement with University of California, San Diego School of Medicine for Transgenic Mouse Model of a-Synucleinopathies 18
PsychoGenics Enters into Licensing Agreement with University of California, San Diego School of Medicine 19
PsychoGenics Enters into Licensing Agreement with McGill University for McGill-R-Thy I-APP 20
PsychoGenics Enters into Licensing Agreement with Yeda Research and Development 21
PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 22
PsychoGenics Enters Into Licensing Agreement With University of South Florida For APP/PS1 Transgenic Mouse Model 23
PsychoGenics Inc – Key Competitors 24
PsychoGenics Inc – Key Employees 25
PsychoGenics Inc – Locations And Subsidiaries 26
Head Office 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
PsychoGenics Inc, Pharmaceuticals & Healthcare, Key Facts 2
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PsychoGenics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PsychoGenics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Blue Oak Pharma Enters into Agreement with PsychoGenics 10
Resilience Therapeutics Enters into Drug Discovery Agreement with PGI 11
PsychoGenics Extends Drug Discovery Agreement with Sunovion Pharma 12
Afraxis And PsychoGenics Enter Into Partnership To Offer Afraxis' ESP Technology For Drug Discovery 13
PsychoGenics Enters into Licensing Agreement with National Institute of Mental Health 14
Amarantus Enters Into Licensing Agreement With PGI Drug Discovery For Eltoprazine 15
PsychoGenics Enters into Licensing Agreement with University of California, San Diego 17
PsychoGenics Enters into Licensing Agreement with University of California, San Diego School of Medicine for Transgenic Mouse Model of a-Synucleinopathies 18
PsychoGenics Enters into Licensing Agreement with University of California, San Diego School of Medicine 19
PsychoGenics Enters into Licensing Agreement with McGill University for McGill-R-Thy I-APP 20
PsychoGenics Enters into Licensing Agreement with Yeda Research and Development 21
PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 22
PsychoGenics Enters Into Licensing Agreement With University of South Florida For APP/PS1 Transgenic Mouse Model 23
PsychoGenics Inc, Key Competitors 24
PsychoGenics Inc, Key Employees 25

List of Figures
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[PsychoGenics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Progressive Corporation:企業の戦略・SWOT・財務情報
    The Progressive Corporation - Strategy, SWOT and Corporate Finance Report Summary The Progressive Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Enphase Energy, Inc. (ENPH)-エネルギー分野:企業M&A・提携分析
    Summary Enphase Energy, Inc. (EEI), formerly PVI Solutions, Inc., is an energy management solutions provider that designs, develops, manufactures and sells microinverter system. Its semiconductor-based microinverter system converts direct current (DC) electricity to alternating current (AC) electric …
  • Nexeon MedSystems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Nexeon MedSystems Inc (Nexeon) is a bioelectronics company that develops and commercializes devices and therapies for the treatment of cardiovascular diseases. The company’s products include embolic protection systems, local drug and biologic delivery systems, nanotechnology-based devices, a …
  • Pt Panorama Sentrawisata Tbk:企業の戦略・SWOT・財務分析
    Pt Panorama Sentrawisata Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Panorama Sentrawisata Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Biogen Inc (BIIB):企業の財務・戦略的SWOT分析
    Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Kautex Textron GmbH & Co. K.G.:企業の戦略・SWOT・財務情報
    Kautex Textron GmbH & Co. K.G. - Strategy, SWOT and Corporate Finance Report Summary Kautex Textron GmbH & Co. K.G. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Qioptiq Group:企業の戦略的SWOT分析
    Qioptiq Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • KCA Deutag Alpha Ltd:企業の戦略的SWOT分析
    KCA Deutag Alpha Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Energy Transfer Partners, L.P.:戦略・SWOT・企業財務分析
    Energy Transfer Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Energy Transfer Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • BioMotiv LLC:医療機器:M&Aディール及び事業提携情報
    Summary BioMotiv LLC (BioMotiv) is a therapeutics licensing and development service provider. The company offers therapeutics across wide disease areas including proteins, small molecules, antibodies, and nucleotides. It portfolio includes psoriasis, inflammatory bowel diseases, cancer, retinitis pi …
  • Nymox Pharmaceutical Corp (NYMX):企業の財務・戦略的SWOT分析
    Nymox Pharmaceutical Corp (NYMX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Brookdale Senior Living Inc (BKD)-製薬・医療分野:企業M&A・提携分析
    Summary Brookdale Senior Living Inc (Brookdale) operates senior living communities which provide properties with high quality service, care and living accommodations for residents. The company focuses on providing an independent living, assisted living, dementia care, skilled nursing, continuing car …
  • Esprinet S.p.A. (PRT):企業の財務・戦略的SWOT分析
    Esprinet S.p.A. (PRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • HoMedics LLC:企業の戦略的SWOT分析
    HoMedics LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Paramedical Srl:企業の製品パイプライン分析2018
    Summary Paramedical Srl (Paramedical) is a medical equipment company that manufactures clinical chemistry, turbidimetry and instruments for laboratories. The company’s products include in vitro diagnostics and equipment, automated immunoassay, brochure regents and instruments, centrifuges, chemistry …
  • Alliance Data Systems Corporation (ADS):企業の財務・戦略的SWOT分析
    Alliance Data Systems Corporation (ADS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Energy Transfer Partners LP (ETP):石油・ガス:M&Aディール及び事業提携情報
    Summary Energy Transfer Partners LP (ETP) is a master limited partnership. It owns and operates diversified portfolio of energy assets in the US. The partnership carries out the gathering, processing, storage, intra- and interstate transportation of natural gas and natural gas liquids. ETP also cond …
  • Advanced Data Systems Corp-医療機器分野:企業M&A・提携分析
    Summary Advanced Data Systems Corp (ADS) is a healthcare technology company that develops medical billing and office automation software tools. The company offers electronic health records, practice management solution, radiology information systems solutions, revenue cycle management services and b …
  • Investors Heritage Capital Corporation:企業の戦略・SWOT・財務情報
    Investors Heritage Capital Corporation - Strategy, SWOT and Corporate Finance Report Summary Investors Heritage Capital Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Korea Electric Power Corporation:発電所・企業SWOT分析
    Korea Electric Power Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆